Modern Medicine Now Top Story

5 things to know about Lyme disease and PowassanThe CDC is warning of a high threat of tick-borne illnesses this summer, including the sometimes-deadly Powassan virus. Here are five things you need to know about Lyme disease and Powassan and how to code for them.
Posters presented at ARVO 2017 offer insight on cosmetic use and OSD, DemodexLeslie E. O’Dell, OD, FAAO, discusses posters she presented about cosmetics and the ocular surface and Demodex with Optometry Times Chief Optometric Editor Ernie Bowling, OD, MS, FAAO, at ARVO 2017 in Baltimore, MD.
Understanding corneal shape helps scleral lens fittingChristine W. Sindt, OD, FAAO, discusses her research in the shape of corneas and constructing the proper scleral lens for each patient with Optometry Times Chief Optometric Editor Ernie Bowling, OD, MS, FAAO, at ARVO 2017 in Baltimore, MD.
New research in how eye, brain health correlate presented at ARVO 2017John G. Flanagan, OD, PhD, FAAO, talks about his research and presentations regarding eye and brain health with Optometry Times Chief Optometric Editor Ernie Bowling, OD, MS, FAAO, at ARVO 2017 in Baltimore, MD.
Pearls from BCLA 2017: CLIDE and blepharitis
Pearls from BCLA 2017: CLIDE and blepharitisThe British Contact Lens Association (BCLA) celebrated its 40th birthday June 9-11 at its 2017 clinical conference and exhibition in Liverpool, UK. Optometry Times was there to hear the latest and live tweet from the meeting.
Top 10 highest, lowest paying states for family medicineWe already told you the top best and worst paying states for internal medicine, but what about family medicine?
Make the most of an EHR demoFormulating what a practice wants to know when evaluating a new system in action can help ensure the best match.
Recent cyberattacks expose physician practice weaknessesSecurity experts say small practices remain vulnerable but can take basic steps to help significantly reduce risk.
Triple directing-acting combination treats decompensated liver diseaseA combination of three drugs successfully treats HCV-infected patients with advanced liver disease.
Liver transplant recipients with HCV fare well under drug comboHepatitis C virus infection in liver transplant recipients can be treated with ledipasvir and sofosbuvir without ribavirin.